Baker Bros. Advisors LP Ionis Pharmaceuticals Inc Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
A detailed history of Baker Bros. Advisors LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 357,915 shares of IONS stock, worth $11.5 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
357,915
Previous 223,470
60.16%
Holding current value
$11.5 Million
Previous $8.95 Million
39.77%
% of portfolio
0.14%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$532 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$457 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$370 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$333 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$254 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.58B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...